How to Prepare Your Biotech Company for the First Regulatory QMS Inspection
- Oct 10, 2025
- 3 min read
For many biotech startups, the first regulatory inspection arrives sooner than expected.
As you approach your First in Human (FiH) trial, authorities such as the EMA or national regulators will expect proof that your organisation has a well-functioning quality management system.

It is not enough to have great science or promising data. Inspectors will look for evidence that your company can manage quality, documentation, and compliance across all outsourced and internal activities.
The key is to have a documented and operational Quality Management System (QMS) that defines responsibilities, ensures GxP compliance, and demonstrates control.
This guide explains what regulators typically look for, the most common compliance mistakes, and how to prepare effectively without spending months writing standard operating procedures from scratch.
What Inspectors Expect During an Audit
Regulators focus on one main question: does the sponsor have a documented and functional QMS that ensures GxP compliance throughout the organisation?
During an FiH inspection, authorities usually review:
The existence of a QMS with approved and signed SOPs
Sponsor responsibilities and delegation of duties
Vendor qualification and oversight of outsourced partners
Training and competence management
Deviation handling, CAPA and change control
Document control, traceability and approval workflows
If one of these elements is missing, compliance becomes difficult to prove, even if the research itself has been performed correctly.
Common QMS Compliance Challenges for Biotech Startups
Even experienced teams often face the same difficulties when it comes to regulatory readiness.

Many start implementing a QMS too late. Building documentation after the fact rarely satisfies inspectors.
Accountability is sometimes unclear, especially when most activities are outsourced.
Smaller organisations often copy complex pharma systems that they cannot maintain.
Training is underestimated, even though a QMS is only as strong as the people who use it.
And finally, SOPs are often written but not truly integrated into daily operations.
How to Become Inspection Ready with QMS
The best approach is to start simple and build structure over time.
Step one: Establish a lean and scalable QMS that matches your company’s size and development stage. A simple system that is actually used is far more valuable than an elaborate one that exists only on paper.
Step two: Focus on the most critical SOPs. These typically cover deviation management, training and competence, supplier qualification, and document control.
Step three: Define roles and responsibilities clearly. Even when tasks are outsourced, the sponsor remains responsible for GxP compliance. Inspectors want to see evidence that you maintain oversight and control.
Step four: Conduct an internal audit. A simulated inspection reveals documentation gaps long before regulators do, and helps your team gain confidence in presenting the system.
The Fast Track: A Turnkey QMS
If your FiH inspection is approaching and time is limited, a turnkey QMS can be the most efficient solution.
At OZQA, we provide a complete and ready to use QMS designed specifically for biotech and life science companies.
Our system includes 13 prevalidated SOPs, document templates, checklists and action lists, along with implementation support and team training.
The system can be implemented in just a few weeks and is fully inspection ready from day one. It aligns with the expectations of EMA, FDA and ICH GxP standards.
You do not just receive documentation, you receive a complete operational compliance framework that works in practice.

Compliance as a Competitive Advantage
A strong QMS is more than a regulatory requirement. It is a strategic asset that builds trust with regulators, investors and partners.
By prioritising quality and compliance early, you position your company as reliable, professional and audit ready. This not only secures smoother study approvals but also strengthens your reputation and long term growth potential.
Ready to Strengthen Your Compliance with QMS?
Contact us for a short consultation and learn how OZQA’s turnkey QMS can help your biotech organisation achieve GxP compliance quickly and confidently.
Read more in the link below to see what QMS service and solutions we provide.



